Biotech start-up SolasCure has announced the completion of its Series A investment round, to support the development of its wound cleaning product, Aurase®. The Cambridge based biotech company has successfully completed its Series A raise of £15m, with funding from industry veterans, institutional ventures and strategic investors.
SolasCure’s mission is to support healthcare professionals with wound care products that significantly improve the health and wellbeing of patients with chronic wounds.
Wellington House East Road Cambridge
Post Code: CB1 1BH
Country: United Kingdom
Membership Type: Corporate 6-20